title: Antibiotic treatment of Lyme borreliosis: what is the evidence?
abstract: Antibiotic treatment of all disease manifestations after infection with Borrelia sensu lato spp aims at resolving the presenting disease manifestation and preventing late stage disease. The goals are resolution of the preventing manifestation and prevention of the spread of bacteria to prevent late disease like arthritis. Different borrelial species prevail in Europe. The natural disease course of European borreliosis is not well defined and the effect of antibiotic treatment is unclear.
authors.affiliation: Medizinische Klinik I, Universitätskliniken des Saarlandes, 66421 Homburg, Germany.
authors.forename: R
authors.initials: R
authors.lastname: Dinser
authors.forename: M C
authors.initials: MC
authors.lastname: Jendro
authors.forename: S
authors.initials: S
authors.lastname: Schnarr
authors.forename: H
authors.initials: H
authors.lastname: Zeidler
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001170:Arthritis, Infectious / Q000188:drug therapy; D018450:Disease Progression; D015787:Erythema Chronicum Migrans / Q000188:drug therapy; D019317:Evidence-Based Medicine; D006801:Humans; D008193:Lyme Disease / Q000188:drug therapy*
chemical_list: D000900:Anti-Bacterial Agents